Drug Trial Radar · NCT01965158
Efficacy and Safety of Naldemedine in the Treatment of Opioid-induced Constipation
Last checked: Nov 20, 2026Latest source record: May 30, 2017 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
547
Actual
Start
Aug 29, 2013
Primary completion
Jan 22, 2015
Study completion Jan 22, 2015
Sponsor
- Lead sponsor
- ShionogiIndustry
- Sponsor type
- Industry
- First posted
- Oct 18, 2013
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years, up to 80 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to evaluate the efficacy and safety of naldemedine in the treatment of opioid-induced constipation (OIC) in adults with non-malignant chronic pain who are not using laxatives.
Conditions
- Opioid-induced Constipation
Interventions
NaldemedineDrug
Naldemedine 0.2 mg tablet taken orally once a day
PlaceboDrug
Placebo tablet taken orally once a day
Primary outcomes
What the sponsor says the trial is designed to measure.
- Percentage of Participants With a Spontaneous Bowel Movement (SBM) ResponseTime frame: 12-week treatment period
Locations
65 sites in 7 countries. Site status is shown where the registry gives one.
Shionogi Research Site
Birmingham, Alabama
Shionogi Research Site
Phoenix, Arizona
Shionogi Research Site
Fresno, California
Shionogi Research Site
Long Beach, California
Shionogi Research Site
National City, California
Shionogi Research Site
North Hollywood, California
Shionogi Research Site
Oceanside, California
Shionogi Research Site
Golden, Colorado
Shionogi Research Site
Miami, Florida
Shionogi Research Site
Miami Springs, Florida
Shionogi Research Site
Orlando, Florida
Shionogi Research Site
Sarasota, Florida
Shionogi Research Site
West Palm Beach, Florida
Shionogi Research Site
Winter Park, Florida
Shionogi Research Site
Marietta, Georgia
Shionogi Research Site
Shreveport, Louisiana
Shionogi Research Site
Caro, Michigan
Shionogi Research Site
Flint, Michigan
Shionogi Research Site
Hazelwood, Missouri
Shionogi Research Site
Las Vegas, Nevada
Shionogi Research Site
Belvidere, New Jersey
Shionogi Research Site
East Brunswick, New Jersey
Shionogi Research Site
Albuquerque, New Mexico
Shionogi Research Site
Great Neck, New York
Shionogi Research Site
Hollis, New York
Shionogi Research Site
New Windsor, New York
Shionogi Research Site
Winston-Salem, North Carolina
Shionogi Research Site
Cincinnati, Ohio
Shionogi Research Site
Oklahoma City, Oklahoma
Shionogi Research Site
Medford, Oregon
Shionogi Research Site
West Reading, Pennsylvania
Shionogi Research Site
Chattanooga, Tennessee
Shionogi Research Site
Arlington, Texas
Shionogi Research Site
Austin, Texas
Shionogi Research Site
Dallas, Texas
Shionogi Research Site
Houston, Texas
Shionogi Research Site
San Antonio, Texas
Shionogi Research Site
Sankt Pölten, Austria
Shionogi Research Site
Vienna, Austria
Shionogi Research Site
Hradec Králové, Czechia
Showing 40 of 65 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.